Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis

The diagnosis of blastomycosis and histoplasmosis can be difficult for clinicians who rarely see infections caused by these environmentally restricted dimorphic fungi. Historically, the diagnosis of blastomycosis has been established by culture and sometimes by histopathologic identification. Curren...

Full description

Bibliographic Details
Main Authors: Kathleen A. Linder, Carol A. Kauffman
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/7/1/12
_version_ 1797543237951422464
author Kathleen A. Linder
Carol A. Kauffman
author_facet Kathleen A. Linder
Carol A. Kauffman
author_sort Kathleen A. Linder
collection DOAJ
description The diagnosis of blastomycosis and histoplasmosis can be difficult for clinicians who rarely see infections caused by these environmentally restricted dimorphic fungi. Historically, the diagnosis of blastomycosis has been established by culture and sometimes by histopathologic identification. Currently, antigen detection in urine and serum has been shown to aid in the rapid diagnosis of blastomycosis, and newer antibody assays are likely to contribute to our diagnostic capability in the near future. The gold standard for the diagnosis of histoplasmosis has been culture of the organism from involved tissues, aided in some patients by histopathological verification of the typical yeast forms in tissues. Antigen detection has contributed greatly to the ability of clinicians to rapidly establish the diagnosis of histoplasmosis, especially in severely ill and immunocompromised patients, and antibody testing for <i>Histoplasma capsulatum</i> provides important adjunctive diagnostic capability for several forms of both acute and chronic histoplasmosis. For both of these endemic mycoses, novel molecular tests are under active investigation, but remain available in only a few reference laboratories. In this review, we provide a synopsis of diagnostic test options that aid in establishing whether a patient has blastomycosis or histoplasmosis.
first_indexed 2024-03-10T13:42:42Z
format Article
id doaj.art-7a376beb82eb40678af12f16fb45c892
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-10T13:42:42Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-7a376beb82eb40678af12f16fb45c8922023-11-21T02:53:38ZengMDPI AGJournal of Fungi2309-608X2020-12-01711210.3390/jof7010012Current and New Perspectives in the Diagnosis of Blastomycosis and HistoplasmosisKathleen A. Linder0Carol A. Kauffman1Infectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, MI 48105, USAInfectious Diseases Section, Veterans Affairs Ann Arbor Healthcare System, University of Michigan Medical School, Ann Arbor, MI 48105, USAThe diagnosis of blastomycosis and histoplasmosis can be difficult for clinicians who rarely see infections caused by these environmentally restricted dimorphic fungi. Historically, the diagnosis of blastomycosis has been established by culture and sometimes by histopathologic identification. Currently, antigen detection in urine and serum has been shown to aid in the rapid diagnosis of blastomycosis, and newer antibody assays are likely to contribute to our diagnostic capability in the near future. The gold standard for the diagnosis of histoplasmosis has been culture of the organism from involved tissues, aided in some patients by histopathological verification of the typical yeast forms in tissues. Antigen detection has contributed greatly to the ability of clinicians to rapidly establish the diagnosis of histoplasmosis, especially in severely ill and immunocompromised patients, and antibody testing for <i>Histoplasma capsulatum</i> provides important adjunctive diagnostic capability for several forms of both acute and chronic histoplasmosis. For both of these endemic mycoses, novel molecular tests are under active investigation, but remain available in only a few reference laboratories. In this review, we provide a synopsis of diagnostic test options that aid in establishing whether a patient has blastomycosis or histoplasmosis.https://www.mdpi.com/2309-608X/7/1/12blastomycosis<i>Blastomyces dermatitidis</i>histoplasmosis<i>Histoplasma capsulatum</i>antigen detection
spellingShingle Kathleen A. Linder
Carol A. Kauffman
Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
Journal of Fungi
blastomycosis
<i>Blastomyces dermatitidis</i>
histoplasmosis
<i>Histoplasma capsulatum</i>
antigen detection
title Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
title_full Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
title_fullStr Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
title_full_unstemmed Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
title_short Current and New Perspectives in the Diagnosis of Blastomycosis and Histoplasmosis
title_sort current and new perspectives in the diagnosis of blastomycosis and histoplasmosis
topic blastomycosis
<i>Blastomyces dermatitidis</i>
histoplasmosis
<i>Histoplasma capsulatum</i>
antigen detection
url https://www.mdpi.com/2309-608X/7/1/12
work_keys_str_mv AT kathleenalinder currentandnewperspectivesinthediagnosisofblastomycosisandhistoplasmosis
AT carolakauffman currentandnewperspectivesinthediagnosisofblastomycosisandhistoplasmosis